황련감초 추출물의 상피지방장벽 생성을 통한 Th2 분화 조절
Effect of Th2 Differentiation Control through Formation of Skin Fat Barrier on Coptidis Rhizoma & Glycyrrhiza Uralensis extract
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This study is conducted to evaluate Th2 skewed condition control through skin fat barrier formation from the treatment using Coptidis Rhizoma and Glycyrrhiza uralensis extract. Methods: The 6-week-old NC/Nga mice were divided into 4 groups: Control group (Ctrl), lipid barrier eliminate treatment group (LBET), Coptidis Rhizoma and Glycyrrhiza uralensis feeding treatment after lipid barrier elimination group (CGFT), dexamethasone feeding treatment after lipid barrier elimination group (DxFT). After 3 days, differences in skin condition, improvement of skin fat barrier, and control of Th2 skewed condition of each group were observed. Results: Pathologic skin damage and tissue changes were less in the CGFT group than in the LBET and DxFT groups, and Transepidermal water loss (TEWL) and pH were also significantly decreased (p < 0.05). The filaggrin intensity and positive response also increased significantly in the CGFT group (p < 0.05). Kallikrein-related peptidase (KLK) 7, Protease activated receptor (PAR)-2, Thymic stromal lymphopoietin (TSLP), Interleukin (IL)-4, and the products of the Th2 differentiation process also showed a significant decrease compared to the LBET and DxFT groups (all p < 0.05). Conclusions: The Coptidis Rhizoma and Glycyrrhiza uralensis extract causes skin barrier recovery and function recovery through the formation of skin fat barrier. This leads to the conclusion that Coptidis Rhizoma and Glycyrrhiza uralensis extract can control Th2 differentiation through the formation of skin fat barrier.
Abstract
Objectives: This study is conducted to evaluate Th2 skewed condition control through skin fat barrier formation from the treatment using Coptidis Rhizoma and Glycyrrhiza uralensis extract. Methods: The 6-week-old NC/Nga mice were divided into 4 groups: Control group (Ctrl), lipid barrier eliminate treatment group (LBET), Coptidis Rhizoma and Glycyrrhiza uralensis feeding treatment after lipid barrier elimination group (CGFT), dexamethasone feeding treatment after lipid barrier elimination group (DxFT). After 3 days, differences in skin condition, improvement of skin fat barrier, and control of Th2 skewed condition of each group were observed. Results: Pathologic skin damage and tissue changes were less in the CGFT group than in the LBET and DxFT groups, and Transepidermal water loss (TEWL) and pH were also significantly decreased (p < 0.05). The filaggrin intensity and positive response also increased significantly in the CGFT group (p < 0.05). Kallikrein-related peptidase (KLK) 7, Protease activated receptor (PAR)-2, Thymic stromal lymphopoietin (TSLP), Interleukin (IL)-4, and the products of the Th2 differentiation process also showed a significant decrease compared to the LBET and DxFT groups (all p < 0.05). Conclusions: The Coptidis Rhizoma and Glycyrrhiza uralensis extract causes skin barrier recovery and function recovery through the formation of skin fat barrier. This leads to the conclusion that Coptidis Rhizoma and Glycyrrhiza uralensis extract can control Th2 differentiation through the formation of skin fat barrier.
참고문헌 (30)
- Ko WS, "Text of Traditional Korean Dermatology & Surgery", pp.37~48 (2007), Sunwoo
- Kim YJ, "The effect of retinoic acid on expression of human beta defensin-2and LL-37 in keratinocyte", J Korean Invest Dermatol, 14(1), pp.29~35 (2007)
- 권민수, "세라마이드가 피부장벽 기능에 미치는 효과", 아시안뷰티화장품학술지, 3(1), pp.131~138 (2005), 한국피부과학연구원
- Kim BB, "7,3’,4’-Trihydroxyisoflavone ameliorates the development of Dermatophagoides farinae-induced atopic dermatitis in NC", Nga mice, 2013, pp.2013, 1~10
- Kelleher M, "Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year", J Allergy Clin Immunol, 135(4), pp.930~935.e1 (2015)
- Kim IR, "Text of Herbology", pp.218~220 (2012), Yonglimsa
- 김희경, "황련이 화상조직에 미치는 항산화와 항염증 및 피부재생 효과", 대한한의학회지, 32(2), pp.1~13 (2011), 대한한의학회
- 정아람, "황련 추출물의 아토피피부염 유발 생쥐에서 피부손상 완화 효과", 동의생리병리학회지, 33(2), pp.102~108 (2019), 한의병리학회[DOI]
- 김남우, "황련의 1,3-Butylene glycol과 혼합 추출물의 항주름 및 항산화 활성", 대한미용학회지, 14(3), pp.267~276 (2018), 대한미용학회[DOI]
- Cho HJ, "Hexane", ethanol extract of Glycyrrhiza uralensis licorice exerts potent anti-inflammatory effects in murine macrophages and in mouse skin, 2010, pp.121(4), 959~966
- 안상현, "황련감초 하태독법의 피부 지방장벽형성 증진효과", 대한한방소아과학회지, 31(3), pp.14~23 (2017), 대한한방소아과학회
- Forslind B, "A domain mosaic model of the skin barrier", Acta Derm Venereol, 74(1), pp.1~6 (1994)
- Kwon YB, "Effects of colostrum on keratinocyte differentiation and wound healing", Korean J Invest Dermatol, 14(2), pp.45~50 (2007)
- Kim HJ, "Atopic dermatitis dermatological understanding and integrated treatment", Kor Soc Skin Barrier Res, 12(1), pp.67~78 (2010)
- Kim JT, "Delayed type hypersensitivity on abdominal skin of mouse by DNCB sensitization", DJIOM, 6(1), pp.117~128 (1997)
- Fluhr JW, "Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity", J Invest Dermatol, 117(1), pp.44~51 (2001)
- Atopic Disease Prevention and Management General Report, "Lee SI", Atopy Environmental Health Center at Samsung Medical Center, 95~ (2012)
- Rogiers V, "EEMCO Guidance for the assessment of transepidermal water loss in cosmetic sciences", Skin Pharmacol Appl Skin Physiol, 14(2), pp.117~128 (2001)
- Lambers H, "Natural skin surface pH is on average below 5, which is beneficial for its residential flora", Int J Cosmet Sci, 28(5), pp.359~370 (2006)
- 김현정, "아토피피부염과 피부 장벽 이상", Allergy Asthma & Respiratory Disease, 1(1), pp.20~28 (2013), 대한 소아알레르기 호흡기학회
- 최응호, "아토피피부염의 병인", 대한의사협회지, 57(3), pp.218~225 (2014), 대한의사협회[DOI]
- Kim HJ, "The effect of skin surface on epidermal permeability barrier", J Skin Barrier Res, 10(1), pp.44~55 (2008)
- Chen JQ, "Roles of kallikrein-related peptidase in epidermal barrier function and related skin diseases", Int J Dermatol Venereol, 2(3), pp.150~155 (2019)
- Yamamoto M, "Kallikrein-related peptidase-7 regulates caspase-14maturation during keratinocyte terminal differentiation by generating an intermediate form", J Biol Chem, 287(39), pp.32825~32834 (2012)
- Yosipovitch G, "What causes itch in atopic dermatitis?", Curr Allergy Asthma Rep, 8, pp.306~311 (2008)
- Briot A, "Kallikrein 5 induces atopic dermatitislike lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome", J Exp Med, 206(5), pp.1135~1147 (2009)
- Demerjian M, "Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2", Am J Pathol, 172(1), pp.86~97 (2008)
- Hatano Y, "Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis", J Invest Dermatol, 124(4), pp.786~792 (2005)
- Kim BE, "Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6", Clin Immunol, 126(3), pp.332~337 (2008)
- Albanesi C, "IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3", J Immunol, 179(2), pp.984~992 (2007)
